Now, the new FDA approval means that patients will be able use the ketamine-derived nasal spray, which is marketed under the ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato ... The drug is the first ketamine-based medicine approved to treat depression. Ketamine has long been seen as a potential ...

Mental health providers in Central Illinois offering ketamine say it has changed patients' lives for the better. Still, only ...

The FDA approved a ketamine nasal spray for treatment-resistant depression in 2018, and several companies operate ketamine therapy centers nationwide. Regulations in Canada, Israel and Switzerland ...

The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for treatment-resistant depression. No More Pricking: US FDA Approves ...

Ketamine therapy is used in the treatment ... LifeStance Health in Oklahoma also provides nasal spray Spravato (esketamine), another therapeutic option for treatment-resistant depression.

The company is developing psychedelics for depression, and hopes to go public within a year of its next published results, per documents seen by BI.

Ketamine is only approved by the FDA as an anesthetic, but there is growing interest in using ketamine products to treat ...

We can help. Stella Mental Health in New York specializes in Spravato (esketamine) nasal spray, ketamine infusion therapy, stellate ganglion blocks (SGB) and integration therapy. Schedule an ...

EAST PEORIA ( 25News Now) - Ketamine therapy is becoming a more popular treatment for resistant mental health disorders, and a treatment center owner in East Peoria said the practice can change lives, ...